NCT03280095View on ClinicalTrials.gov

Bioequivalence Study of Co-codamol 15mg/500mg Capsules vs Co-codamol 30mg/500mg Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 23, 2014

Primary Completion Date

December 12, 2014

Study Completion Date

December 12, 2014

Conditions
Healthy
Interventions
DRUG

co-codamol 15mg/500mg capsule

DRUG

co-codamol 30mg/500mg tablet

Trial Locations (1)

BT2 7BA

BioKinetic Europe Ltd, Belfast

All Listed Sponsors
lead

Galen Limited

INDUSTRY

NCT03280095 - Bioequivalence Study of Co-codamol 15mg/500mg Capsules vs Co-codamol 30mg/500mg Tablets in Healthy Subjects | Biotech Hunter | Biotech Hunter